farnesol and Viremia

farnesol has been researched along with Viremia in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Galkina, SA; Joshi, P; Kosikova, G; Moreno, ME; Murphey-Corb, M; Parniak, MA; Reeve, AB; Rivera, JM; Sarafianos, SG; Sloan, B; Stoddart, CA1

Other Studies

1 other study(ies) available for farnesol and Viremia

ArticleYear
Oral administration of the nucleoside EFdA (4'-ethynyl-2-fluoro-2'-deoxyadenosine) provides rapid suppression of HIV viremia in humanized mice and favorable pharmacokinetic properties in mice and the rhesus macaque.
    Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:7

    Topics: Animals; Anti-HIV Agents; Blood-Brain Barrier; Diazonium Compounds; Farnesol; Flow Cytometry; Half-Life; HIV Infections; HIV-1; Humans; In Vitro Techniques; Macaca mulatta; Mice; Mice, SCID; Monocytes; Reverse Transcriptase Inhibitors; RNA, Viral; Simian Immunodeficiency Virus; Viremia

2015